Also interesting
EXO Biologics raises €16 million for exosome therapeutic development and clinical supply
The funding will support ongoing and future clinical trials, continue its manufacturing expansion, and expand strategic partnerships.
Work-study programs: a springboard to biomanufacturing jobs?
Wallonia is developing new work-study programs to enable students to learn biomanufacturing both through teaching and experience in the workplace.
Cell Matters acquired by global leader Cryoport
After a strategic partnership to deliver end-to-end cryopreservation services for leukapheresis derived therapies, Cryoport acquired Cell Matters.